Efficacy of fludarabine and mitoxantrone combination regimen in indolent lymphoma and chronic lymphocytic leukemia and the correlation of anti-apoptosis SURVIVIN protein with indolent lymphoma and chronic lymphocytic leukemia : A prospective study /
دراسة مستقبلية لتقييم كفاءة عقاري الفلوداربين و الميتوكسانترون مجتمعين في علاج سرطان الدم الليمفاوي المزمن و مرض اللاهودجكين من الدرجة الأولية و علاقة المرضين مع مضادات الموت المبرمج (سيرفافين) بروتين
Amal Shaker Zakariz ; Supervised Farouk Ahmed Haggag , Emad Hamada , Amina Abdelwahid
- Cairo : Amal Shaker Zakariz , 2009
- 126 P. : charts ; 25cm
Thesis (Ph.D.) - Cairo University - Faculty of Medicine - Department of Oncology-Radiation
We conducted our study in onncology department in Kasr Elaini hospital on 21 patients who presented to our department during period from August 2004 to April 2009. Patients iccluded in the study were CLL and low grade lymphoma cases who are going to receive fludarabine and mitoxantrone (FN) chemotherapy combination for 6 cycles